Controlled Decompression Alleviates Brain Injury via Attenuating Oxidative Damage and Neuroinflammation in Acute

Chonghui Zhang1, Xiao Qian1, Jie Zheng1

  • 1Department of Neurosurgery, The 904th Hospital of PLA, Medical School of Anhui Medical University, Wuxi, Jiangsu 214044, China.

Insights

Controlled decompression (CDC) offers better neuroprotection than rapid decompression (RDC) for acute intracranial hypertension. CDC reduces brain damage by lowering oxidative stress, inflammation, and specific protein levels (UCH-L1 and GFAP).

Area of Science:

  • Neurosurgery
  • Neuroscience
  • Biomedical Engineering

Background:

  • Clinical studies confirm controlled decompression (CDC) benefits acute intracranial hypertension (AICH) patients, mitigating complications from rapid decompression (RDC).
  • This study investigates the therapeutic potential of CDC using ubiquitin C-terminal hydrolase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) in an AICH rabbit model.

Purpose of the Study:

  • To evaluate the neuroprotective efficacy of CDC compared to RDC.
  • To elucidate the molecular mechanisms underlying CDC's therapeutic effects in AICH, focusing on UCH-L1 and GFAP.

Main Methods:

  • Male New Zealand white rabbits were divided into sham-operated, CDC, and RDC groups.
  • Plasma and brain tissue were analyzed for UCH-L1, GFAP, oxidative stress markers, and inflammatory cytokines using ELISA and Western blot.
  • Neurological scores, brain water content, and protein expression via qPCR and immunofluorescence were assessed.

Main Results:

  • CDC significantly improved neurological function and reduced brain water content compared to RDC.
  • CDC attenuated neuronal degeneration, oxidative damage, and inflammatory responses more effectively than RDC.
  • Plasma UCH-L1 and GFAP levels were significantly lower in the CDC group post-operation.

Conclusions:

  • Controlled decompression (CDC) demonstrates superior neuroprotective effects compared to rapid decompression (RDC) in an acute intracranial hypertension model.
  • CDC attenuates oxidative damage and inflammatory responses.
  • CDC downregulates UCH-L1 and GFAP levels, contributing to its neuroprotective benefits.
Abstract

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...